| Trial of sodium phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis S Paganoni, EA Macklin, S Hendrix, JD Berry, MA Elliott, S Maiser, ... New England Journal of Medicine 383 (10), 919-930, 2020 | 461 | 2020 |
| Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial GK Wilcock, SE Black, SB Hendrix, KH Zavitz, EA Swabb, MA Laughlin The Lancet Neurology 7 (6), 483-493, 2008 | 346 | 2008 |
| Sensory, mechanical, and microscopic evaluation of staling in low‐protein and gluten‐free breads GJ Ahlborn, OA Pike, SB Hendrix, WM Hess, CS Huber Cereal chemistry 82 (3), 328-335, 2005 | 322 | 2005 |
| 24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial H Soininen, A Solomon, PJ Visser, SB Hendrix, K Blennow, M Kivipelto, ... The Lancet Neurology 16 (12), 965-975, 2017 | 223 | 2017 |
| Lecanemab: appropriate use recommendations J Cummings, L Apostolova, GD Rabinovici, A Atri, P Aisen, S Greenberg, ... The journal of prevention of Alzheimer's disease 10 (3), 362-377, 2023 | 222 | 2023 |
| Report of the task force on designing clinical trials in early (predementia) AD PS Aisen, S Andrieu, C Sampaio, M Carrillo, ZS Khachaturian, B Dubois, ... Neurology 76 (3), 280-286, 2011 | 198 | 2011 |
| Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis S Paganoni, S Hendrix, SP Dickson, N Knowlton, EA Macklin, JD Berry, ... Muscle & nerve 63 (1), 31-39, 2021 | 175 | 2021 |
| Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force B Vellas, MC Carrillo, C Sampaio, HR Brashear, E Siemers, H Hampel, ... Alzheimer's & Dementia 9 (4), 438-444, 2013 | 161 | 2013 |
| Safety, tolerability, pharmacokinetics, and Aβ levels after short-term administration of R-flurbiprofen in healthy elderly individuals DR Galasko, N Graff-Radford, S May, S Hendrix, BA Cottrell, SA Sagi, ... Alzheimer Disease & Associated Disorders 21 (4), 292-299, 2007 | 156 | 2007 |
| Nilvadipine in mild to moderate Alzheimer disease: a randomised controlled trial B Lawlor, R Segurado, S Kennelly, MGM Olde Rikkert, R Howard, ... PLoS medicine 15 (9), e1002660, 2018 | 147 | 2018 |
| ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials J Wang, V Logovinsky, SB Hendrix, SH Stanworth, C Perdomo, L Xu, ... Journal of Neurology, Neurosurgery & Psychiatry 87 (9), 993-999, 2016 | 143 | 2016 |
| An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease JB Langbaum, SB Hendrix, N Ayutyanont, K Chen, AS Fleisher, RC Shah, ... Alzheimer's & Dementia 10 (6), 666-674, 2014 | 143 | 2014 |
| 36‐month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease H Soininen, A Solomon, PJ Visser, SB Hendrix, K Blennow, M Kivipelto, ... Alzheimer's & dementia 17 (1), 29-40, 2021 | 122 | 2021 |
| The Alzheimer's Prevention Initiative Autosomal-Dominant Alzheimer's Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to … PN Tariot, F Lopera, JB Langbaum, RG Thomas, S Hendrix, LS Schneider, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 4 …, 2018 | 119 | 2018 |
| Aducanumab: appropriate use recommendations update J Cummings, GD Rabinovici, A Atri, P Aisen, LG Apostolova, S Hendrix, ... The journal of prevention of Alzheimer's disease 9 (2), 221-230, 2022 | 118 | 2022 |
| A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study M Boada, OL López, J Olazarán, L Núñez, M Pfeffer, M Paricio, J Lorites, ... Alzheimer's & Dementia 16 (10), 1412-1425, 2020 | 110 | 2020 |
| Multivariate analysis for the biobehavioral and social sciences: A graphical approach BL Brown, SB Hendrix, DW Hedges, TB Smith John Wiley & Sons, 2011 | 105 | 2011 |
| The Alzheimer's Prevention Initiative Generation Program: study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's disease CL Lopez, PN Tariot, A Caputo, JB Langbaum, F Liu, ME Riviere, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 104 | 2019 |
| The clinical practice of risk reduction for Alzheimer's disease: a precision medicine approach RS Isaacson, CA Ganzer, H Hristov, K Hackett, E Caesar, R Cohen, ... Alzheimer's & Dementia 14 (12), 1663-1673, 2018 | 103 | 2018 |
| The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 … N Ayutyanont, JBS Langbaum, SB Hendrix, K Chen, AS Fleisher, ... The Journal of clinical psychiatry 75 (6), 727, 2014 | 101 | 2014 |
